News

(Bloomberg) -- JPMorgan Chase & Co.’s stock traders took in a record haul in the first quarter, boosted by chaotic market moves set off by President Donald Trump’s policy announcements after he took office in January. Most Read from BloombergThe Secret Formula for Faster TrainsMidtown Office Building Evacuated on Concerns of Wall CollapseIn Chicago, a Former Steel Mill Looks to Make a Quantum LeapNYC Tourist Helicopter Crashes in Hudson River, Killing SixInside the Quiet, Extravagant Expansion o

Walmart, Target initiated: Wall Street's top analyst calls

JOHANNESBURG (Reuters) -Turmoil in the wake of U.S. President Donald Trump's tariff hikes has abruptly stalled emerging market sovereign debt sales in April, after issuance from developing nations and companies shattered first-quarter records. April is usually a busy month for emerging market debt sales on international capital markets, but policy uncertainty, fears of global recession and spiking U.S. yields have choked risk appetite. This is in sharp contrast to the first quarter, where emerging market firms issued $150 billion and sovereigns $89 billion, according to calculations from JPMorgan.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 14.1%. This performance was worse than the S&P 500’s 9.3% decline.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.